AdComconf 0.85

imetelstat — AdCom

$GERN · GERON CORP · transfusion-dependent anemia in adult patients with low- to intermediate-1 risk myelodysplastic syndromes who have failed to respond, or have lost response to, or are ineligible for erythropoiesis-stimulating agents

Event date

Date TBD

Sponsor runway

3 mo

$68.9M liquid

Evidence

“the FDA informed the Company that it is currently planning to hold an advisory committee meeting as part of the NDA review”

Source: 8-K filed 2023-08-22View on EDGAR ↗0000950170-23-043949

Comparable historical adcoms· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

No insider Form 4 activity reported on $GERN in the 90 days around this event.

← All catalysts for $GERN